Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy for Recurrent Epithelial Ovarian Cancer

Clinical trial NCT06366490 · RECRUITING

Trial details

NCT number: NCT06366490
Sponsor: PhotonPharma, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Recurrent Epithelial Ovarian Cancer Which Includes Epithelial Ovarian, Fallopian Tube and/or Primary Peritoneal Cancer

Start date: 2026-02-12
Primary completion: 2026-11-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.